Foamix Pharmaceuticals Ltd. (FOMX) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 126 transactions totaling $1.2M, demonstrating a bearish sentiment with -$176.9K in net insider flow. The most recent transaction on Mar 9, 2020 involved a transaction of 62,647 shares valued at $0.
No significant insider buying has been recorded for FOMX in the recent period.
No significant insider selling has been recorded for FOMX in the recent period.
Based on recent SEC filings, insider sentiment for FOMX is bearish with an Insider Alignment Score of 42/100 and a net flow of -$176.9K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Foamix Pharmaceuticals Ltd. (FOMX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading FOMX stock, having executed 126 transactions in the past 90 days. The most active insider is Aharon Schwartz (Executive), who has made 4 transactions totaling $437.8K.
Get notified when executives and directors at FOMX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 9, 2020 | D. Bruno Anthony | Executive | Disposition | 62,647 | $N/A | $0 | |
| Mar 9, 2020 | D. Bruno Anthony | Executive | Disposition | 12,360 | $N/A | $0 | |
| Mar 9, 2020 | Domzalski David | Executive | Disposition | 90,902 | $N/A | $0 | |
| Mar 9, 2020 | Domzalski David | Executive | Disposition | 233,126 | $N/A | $0 | |
| Mar 9, 2020 | Hadar Ilan | Executive | Disposition | 14,077 | $N/A | $0 | |
| Mar 9, 2020 | Hadar Ilan | Executive | Disposition | 116,501 | $N/A | $0 | |
| Mar 9, 2020 | Harsch Mutya | Executive | Disposition | 85,490 | $N/A | $0 | |
| Mar 9, 2020 | Harsch Mutya | Executive | Disposition | 12,742 | $N/A | $0 | |
| Mar 9, 2020 | Hirsch Stanley | Executive | Disposition | 52,842 | $N/A | $0 | |
| Mar 9, 2020 | Hirsch Stanley | Executive | Disposition | 59,016 | $N/A | $0 | |
| Mar 9, 2020 | Hirsch Stanley | Executive | Disposition | 182,500 | $N/A | $0 | |
| Mar 9, 2020 | Kazanchyan Anna | Executive | Disposition | 15,714 | $N/A | $0 | |
| Mar 9, 2020 | Kazanchyan Anna | Executive | Disposition | 43,030 | $N/A | $0 | |
| Mar 9, 2020 | Schwartz Aharon | Executive | Disposition | 112,200 | $N/A | $0 | |
| Mar 9, 2020 | Stuart Iain | Executive | Disposition | 91,303 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 40 | $665.2K | 46.6% |
Purchase(P) | 4 | $488.4K | 34.2% |
Exercise(M) | 17 | $113.2K | 7.9% |
Award(A) | 34 | $74.4K | 5.2% |
Payment(F) | 10 | $54.5K | 3.8% |
Exercise (Options)(X) | 1 | $31.4K | 2.2% |
Disposition(D) | 20 | $0 | 0.0% |
Insider activity at Foamix Pharmaceuticals Ltd. shows mixed signals across all time. While $488.4K in purchases indicates some executive confidence,$665.2K in sales balances the picture, resulting in a modest net flow of -$176.9K.16 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Aharon Schwartz, has transacted $437.8K during this period.